Open source
Multi-Agent Drug Discovery (MADD)
Drug design against a named target, with every claim audited.
You name the target - a disease, a receptor, a genetic
disorder, or a molecular target in a disease context - and
MADD works it end to end. AI research agents study the
target from evidence retrieved for it, working blind; a
structured debate decides whether that evidence supports
locking a design specification; only then do designer
models propose candidate compounds, which are audited,
computed on, and ranked. Each ranked candidate receives a
production sheet stating what would be made, its computed
identity, its production route, and whatever the designer
did not specify, named as unspecified.
The system's rule is plain: no claim counts unless it rests
on a real, checkable primary source, and no model grades
its own homework. Mechanical auditors, not the models,
strike claims that are unsourced, malformed, retracted, or
unsupported by the source they cite, and scoring is
deterministic arithmetic over the evidence that survives.
Status, plainly: the pipeline has run end to end in
validation runs staffed by agents of a single model family.
Two target runs produced ranked, gate-passing candidates;
those candidates are computational proposals, and none has
been made or assayed. Four calibration runs against the
built-in retrospective test set each failed exactly one of
the pass thresholds fixed in advance, and no scored
production run has taken place. The full validation record
is published in the repository, and the whitepaper reports
it as it stands.
- Blinded multi-agent research with mechanical claim and citation audits
- Gate 0: a retrospective test set of eight real drug programs
- Deterministic scoring from audited evidence only
- Apache-2.0, provider-neutral, standard-library core
Read the whitepaper (PDF) →
View the source on GitHub →
Try the live console demo →
The live demo is a variant of MADD reimplemented to run on the AI Studio platform. It presents the project's real recorded runs and data, but it is not the canonical codebase, and it previews a possible release-candidate direction rather than a released version.